SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19.

Serological immune responses after COVID-19 show considerable inter-individual variability, but show an association with increasing age and higher severity of disease. IgG-type anti-SARS-CoV-2 antibodies remain positive in 90% of the individuals 30 weeks after onset of symptoms.